###begin article-title 0
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
Genetic Variations in HSPA8 Gene Associated with Coronary Heart Disease Risk in a Chinese Population
###end article-title 0
###begin p 1
Conceived and designed the experiments: MH RMT TW. Performed the experiments: MH HG XY LZ XZ LC HZ. Analyzed the data: MH HG XY LZ XZ HZ FBH TW. Contributed reagents/materials/analysis tools: LC TW. Wrote the paper: MH HG FBH RMT TW.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 291 296 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 341 347 <span type="species:ncbi:9606">people</span>
There is ample evidence that Hsp70 takes part in the progress of coronary heart disease (CHD). This implies that genetic variants of Hsp70 genes such as HSPA8 (HSC70) gene might contribute to the development of CHD. The present study aimed to investigate whether certain genetic variants of HSPA8 gene are associated with CHD in Han Chinese people.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 732 733 732 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 835 839 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCGC</italic>
###xml 904 905 904 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 950 954 950 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AGGT</italic>
A total of 2006 subjects (1003 CHD cases and 1003 age- and sex- matched healthy controls) were recruited. Genetic variants in the HSPA8 gene were identified by sequencing of the gene in 60 unrelated Chinese. Four tag single nucleotide polymorphisms (tagSNPs) (rs2236659, rs2276077, rs10892958, and rs1461496) were selected and genotyped. The function of the significant SNP was evaluated using luciferase reporter assays in two cell lines. By sequencing the promoter and all exons and introns of the HSPA8 gene, 23 genetic variants were identified. One promoter SNP rs2236659 was associated with susceptibility to CHD. Carriers of the "C" allele of rs2236659 had decreased CHD risk with odds ratio (OR) of 0.78 (95% CI: 0.62, 0.98; P = 0.033) after adjustment for conventional risk factors. Haplotype analyses indicated that haplotype GCGC contributed to a lower CHD risk (OR = 0.78, 95% CI: 0.65, 0.93; P = 0.006) compared with the common haplotype AGGT. In a transfection assay, the C allele of rs2236659 showed a 37-40% increase in luciferase expression of the reporter gene luciferase in endothelial and non-endothelial cells compared with the T allele.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
These findings suggest that genetic variants in HSPA8 gene (especially promoter SNP rs2236659) contribute to the CHD susceptibility by affecting its expression level.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 328 331 328 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Hartl1">[1]</xref>
###xml 463 466 463 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Kampinga1">[2]</xref>
###xml 665 668 665 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Daugaard1">[3]</xref>
###xml 670 673 670 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Giffard1">[4]</xref>
###xml 788 791 788 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Daugaard1">[3]</xref>
###xml 891 894 891 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Daugaard1">[3]</xref>
###xml 1094 1097 1094 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Chong1">[5]</xref>
###xml 1099 1102 1099 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Su1">[6]</xref>
###xml 1185 1188 1185 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Johnson1">[7]</xref>
###xml 1189 1192 1189 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Bolla1">[9]</xref>
###xml 1278 1284 1278 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA1A</italic>
###xml 1331 1335 1331 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-He1">[10]</xref>
###xml 336 342 <span type="species:ncbi:9606">humans</span>
Coronary heart disease (CHD) is a complex disease with high morbidity and mortality. Very little is known about its genetic etiology. Heat shock protein 70 (HSP70), as a dominant chaperone in the HSPs families, can help in the assembly of newly synthesized proteins, in protein transport, and in the removal of damaged proteins [1]. In humans, the HSP70kDa family comprises 13 members, some of which show constitutive expression while others are stress inducible [2]. These isoforms have highly homogenous structure. They are all composed of a conserved ATPase domain, a peptide-binding domain, a middle region with protease sensitive sites, and a C-terminal domain[3], [4]. For instance, HSPA8, previously referred to as HSP73 or HSC70, shares 86% amino acid homology to inducible HSPA1A[3]. Consistent with their homogenous structure, these proteins have distinct but overlapping functions[3]. Thus both stress-inducible Hsp70 and constitutively expressed HSPA8 can perform some similar functions and are capable of protecting cardiac muscle cells against injuries like an oxidative challenge[5], [6]. There is much evidence indicating that Hsp70 can take part in the progress of CHD[7]-[9]. A previous study from our laboratory also demonstrated that genetic variants in the HSPA1A gene may be novel genetic risk markers for CHD[10]. Based on their high degree of structural homology and similar function in protecting against injuries in cardiac muscle cell, it is conceivable that the main constitutively-expressed member of the HSP70 family, HSPA8 might also be involved in the development of CHD and that single nucleotide polymorphisms (SNPs) and haplotypes of this gene may be associated with CHD and contribute to CHD susceptibility.
###end p 9
###begin p 10
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
To test this hypothesis, we first sequenced and identified all SNPs in the HSPA8 gene in 60 unrelated Han Chinese. We then selected 4 tagging SNPs (tagSNPs) to identify potential genetic markers of this gene for CHD susceptibility in a case-control study comprised of 1,003 CHD cases and 1,003 age- and sex- frequency matched controls in a Chinese population. We also examined the function of the SNPs associated with CHD susceptibility by performing a reporter gene luciferase activity assay in two types of cell lines.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
SNPs Identification in the HSPA8 Gene in Han Chinese
###end title 12
###begin p 13
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 106 113 106 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 106 113 106 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009684-t001"><bold>Table 1</bold></xref>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 204 205 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 282 284 282 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ca</italic>
###xml 360 367 360 367 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 360 367 360 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009684-t001"><bold>Table 1</bold></xref>
In total we found 23 genetic variants in HSPA8 gene with minor allele frequency (MAF) from 5.0% to 45.0% (Table 1). Among those, 6 novel SNPs had not been reported previously, including 301 c/g and 395 c/g (intron 1), 1255 t/c (intron 2), 1671 c/t (intron 3), 2692 gactc/- and 2716 ca/- (intron 5); The remaining 17 SNPs have been reported in NCBI as shown in Table 1 (). SNP rs11218942 (G > T> C) is triallelic and was not analyzed in further linkage disequilibrium analysis and tagSNPs selection.
###end p 13
###begin title 14
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
Variants discovered by sequencing all HSPA8 exons and introns and 1 Kb upstream of transcript start site in 60 unrelated Chinese.
###end title 14
###begin p 15
*Reference the transcription start code as +1.
###end p 15
###begin p 16
Novel SNP not reported in public database before.
###end p 16
###begin title 17
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
Selection of tagSNPs in HSPA8 Gene
###end title 17
###begin p 18
###xml 138 146 138 146 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</bold>
###xml 138 146 138 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009684-g001"><bold>Figure 1</bold></xref>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Ding1">[11]</xref>
###xml 317 325 317 325 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</bold>
###xml 317 325 317 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009684-g002"><bold>Figure 2</bold></xref>
Based on the above sequencing data, linkage disequilibrium analysis results showed that all detected SNPs located in the same haploblock (Figure 1). The htSNPer1.0 software was used to pick out the tagSNPs[11], and finally four SNPs were selected as tagSNPs, including rs2236660, rs2236658, rs10892958 and rs1461496 (Figure 2). Because the sequences around the SNPs rs2236660 and rs2236658 are rich in GC and not suitable to be detected by TaqMan SNP allelic discrimination assay, we selected the other two SNPs rs2236659 and rs2276077, which are in high linkage with rs2236660 and rs2236658 for further analysis.
###end p 18
###begin title 19
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
Linkage disequilibrium (D' and r2) between single nucleotide polymorphisms in HSPA8 gene.
###end title 19
###begin p 20
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 177 178 177 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Based on the data on the resequencing of the HSPA8 gene, a total of 22 single nucleotide polymorphisms were analyzed by JLIN software to analyze linkage disequilibrium (D' and r2) between SNPs.
###end p 20
###begin title 21
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
Construction of haplotype and tagging SNPs selection in HSPA8 gene.
###end title 21
###begin p 22
A total of 22 single nucleotide polymorphisms (SNPs) were analyzed by htSNPer1.0 software to select tagSNPs. 1.0 indicated rs2236660 and 22.0, the last SNP rs4802. The results showed that rs2236660, rs2236658, rs10892958 and rs1461496 were selected for tagSNPs.
###end p 22
###begin title 23
General Characteristics of the Subjects
###end title 23
###begin p 24
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-He2">[12]</xref>
###xml 124 131 124 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 124 131 124 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009684-t002"><bold>Table 2</bold></xref>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
###xml 356 364 <span type="species:ncbi:9606">patients</span>
The general characteristics of the CHD cases and controls have been described in a previous study[12] and are summarized in Table 2. CHD patients had a higher prevalence of conventional vascular risk factors, including smoking, non-drinking, history of hypertension and diabetes mellitus, family history of CHD and higher level of FBG, whereas TC level in patients were surprisingly lower than in controls probably due to cholesterol-lowering treatment in the cases.
###end p 24
###begin title 25
###xml 49 50 49 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt103">*</xref>
General characteristics of CHD cases and controls*.
###end title 25
###begin p 26
*Data are means (standard deviation) for continuous variables and n (%) for categorical variables.
###end p 26
###begin title 27
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
HSPA8 Genotypes and CHD Risk
###end title 27
###begin p 28
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 91 98 91 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</bold>
###xml 91 98 91 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009684-t003"><bold>Table 3</bold></xref>
###xml 242 243 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 765 766 765 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 841 842 841 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 866 873 866 873 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</bold>
###xml 866 873 866 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009684-t003"><bold>Table 3</bold></xref>
###xml 1492 1493 1490 1491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1019 1022 <span type="species:ncbi:9606">men</span>
The genotype frequencies of the four studied SNPs in HSPA8 polymorphisms are summarized in Table 3. The distributions of SNPs rs2236659, rs2276077, rs10892958 and rs1461496 did not depart from the Hardy-Weinberg equilibrium in control group (P = 0.73, 0.62, 0.79 and 0.22 respectively). There was significant difference in genotype distribution of rs2236659 between CHD and controls. Adjustment for the conventional risk factors such as age, sex, pack-years of smoking, drinking, activity, hypertension, DM and family history of CHD did not appreciably alter the results. Compared with TT genotype of rs2236659, subjects with C allele had lower risk of CHD after adjustment for the conventional risk factors above (Crude odds ratio (OR) = 0.83, 95% CI: 0.69, 1.00; P = 0.049 and adjusted OR = 0.78, 95% confidence interval (CI): 0.62, 0.98; P = 0.033 respectively) (Table 3). Stratified analysis according to age (</=60 years and >60 years), sex and smoking status indicated that subjects with C allele of rs2236659 in men, older (>60 years) or smokers subgroups had significant lower risk of CHD. However in females, younger or non-smokers subgroups there were no significant differences. Further analysis indicated that there were no interactions between SNP rs2236659 and above factors respectively (data not shown). There were no significant differences between CHD and control group in SNPs of rs2276077, rs10892958 and rs1461496 before or after adjusting for conventional risk factors (P >0.05).
###end p 28
###begin title 29
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
Analysis of associations between the HSPA8 polymorphisms and risk of CHD.
###end title 29
###begin p 30
*Adjusted for age, sex, pack-years of smoking, drinking, activity, hypertension, diabetes milletus and family history of CHD.
###end p 30
###begin p 31
###xml 6 7 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 31 32 14 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 55 56 27 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 72 73 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
daggerP = 0.043, double dagger P = 0.025, section sign P = 0.049, and ||P = 0.033 respectively when compared with TT genotype of rs2236659.
###end p 31
###begin title 32
Haplotype Associations with CHD Risk
###end title 32
###begin p 33
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Stephens1">[13]</xref>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AGGT</italic>
###xml 341 345 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCGT</italic>
###xml 347 351 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCGC</italic>
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGAT</italic>
###xml 362 366 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGGT</italic>
###xml 638 643 638 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 740 744 740 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AGGT</italic>
###xml 750 754 750 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCGC</italic>
###xml 823 824 823 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 854 858 854 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCGT</italic>
###xml 889 893 889 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCGC</italic>
###xml 952 956 952 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AGGT</italic>
###xml 989 990 989 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1111 1118 1111 1118 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 4</bold>
###xml 1111 1118 1111 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009684-t004"><bold>Table 4</bold></xref>
All the pairwise LD measure D' of the four investigated tagSNPs in the HSPA8 gene ranged from 0.90 to 0.96 (data not shown). A total of 14 and 12 haplotypes were estimated in the CHD and control groups respectively by using PHASE 2.0 software to reconstruct haplotypes based on the observed genotypes[13]. Among these, 5 haplotypes of AGGT, GCGT, GCGC, GGAT and GGGT were >1.0% (from left to right the order of polymorphic bases in haplotype is rs1461496, rs10892958, rs2276077, and rs2236659). The associations between the common haplotypes (covering 96.95% and 98.16% of allelic variance in CHD and controls, respectively) encompassing HSPA8 polymorphisms and CHD risk were also examined. Compared with the highest-frequency haplotype of AGGT, the GCGC haplotype had 22% lower risk of CHD (OR = 0.78, 95% CI: 0.65, 0.93; P = 0.006). However, haplotype GCGT, which is only different from GCGC in rs2236659, had no significant difference compared with AGGT (OR = 1.00, 95% CI: 0.85, 1.17; P = 0.958), confirming the results of single SNP analyses that subjects with C allele of rs2236659 had lower risk of CHD (Table 4).
###end p 33
###begin title 34
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
Haplotype distribution of HSPA8 in CHD and control group.
###end title 34
###begin p 35
*Polymorphic bases were in 3' to 5' order and from left to right the order is rs1461496, rs10892958, rs2276077 and rs2236659.
###end p 35
###begin p 36
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACGT</italic>
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGGC</italic>
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AGGC</italic>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AGAT</italic>
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCAT</italic>
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACGC</italic>
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AGAC</italic>
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGAC</italic>
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACAC</italic>
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACAT</italic>
Other haplotype includes ACGT, GGGC, AGGC, AGAT, GCAT, ACGC, AGAC, GGAC, ACAC, and ACAT with frequency <1.0%.
###end p 36
###begin title 37
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
HSPA8 Promoter Region Carrying the -357C (rs2226659) Leads to Higher Expression in a Reporter Assay
###end title 37
###begin p 38
###xml 128 136 128 136 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3</bold>
###xml 128 136 128 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009684-g003"><bold>Figure 3</bold></xref>
###xml 313 314 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
In order to understand the functional significance of the-357 T/C change, we used a reporter assay with luciferase. As shown in Figure 3, relative luciferase expression driven by the T-C-G containing promoter were 37-40% higher than that by the haplotype T-T-G containing promoter in the two types of cell lines (P = 0.008 for HBE and 0.046 for HUVEC). Because the two haplotypes of T-C-G and T-T-G are only different in -357T/C, these results suggested that the -357C variant (rs2236659) had a higher promoter activity than -357T allele. Similar results were obtained for the T-T-A haplotype when comparing with haplotypes T-T-G or C-C-G in HBE; however, there were no significant differences observed in HUVEC cells
###end p 38
###begin title 39
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
Effects of haplotypes in promoter of HSPA8 on luciferase activity.
###end title 39
###begin p 40
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 823 824 818 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 122 127 <span type="species:ncbi:9606">human</span>
###xml 165 170 <span type="species:ncbi:9606">human</span>
###xml 479 483 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Transient luciferase reporter gene expression assays with constructs containing different haplotypes of HSPA8 promoter in human bronchial epithelial cells (HBE) and human umbilical vein endothelial cells (HUVEC). Upper: schematic representation of different reporter gene constructs. Variants of -703C/T, -357C/T, and -308A/G represent rs2236660, rs2236659, and rs2236658 respectively; Lower: luciferase expression of these constructs. All constructs were cotransfected with pRL-SV40 to standardize the transfection efficiency. Fold increase of luciferase activity was calculated by defining the activity of the empty pGL3-Basic vector as 1. All experiments were performed in triplicates at least in three independent transfection experiments and each value represents mean (standard deviation). *and dagger indicated that P<0.05, compared with each of the construct.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
Our study is the first one to examine the associations of variants of a constitutively expressed member of the HSP70 family, HSPA8 and CHD susceptibility. Subjects with the C allele of rs2236659 had lower risk of CHD independent of other conventional risk factors. Further functional study in a cell reporter assay suggested that this association might be due to the increased promoter activity of the C allele of rs2236659 which may result in higher levels of expression of this HSPA8 protein.
###end p 42
###begin p 43
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Erbse1">[14]</xref>
###xml 264 267 264 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Giffard1">[4]</xref>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Garrido1">[15]</xref>
###xml 380 383 380 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Chong1">[5]</xref>
###xml 530 534 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Mugge1">[16]</xref>
###xml 548 553 548 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 774 778 774 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Mugge1">[16]</xref>
###xml 779 783 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Steinberg1">[18]</xref>
###xml 855 858 855 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Chong1">[5]</xref>
###xml 1045 1049 1045 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Yun1">[19]</xref>
###xml 1102 1106 1102 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-delaRosa1">[20]</xref>
###xml 1305 1308 1305 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Giffard1">[4]</xref>
###xml 1310 1314 1310 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Mosser1">[21]</xref>
###xml 1658 1662 1658 1662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Durand1">[22]</xref>
HSPA8 is constitutively expressed and only mildly induced during stress situations[14]. It plays an important role in folding protein during their synthesis, transporting protein across membranes, regulating stress response and it is also involved in cell survival[4], [15]. In cardiac muscle cells, overexpression of HSPA8 attenuated oxidative injuries and enhanced cell survival[5]. This implies that HSPA8 might participate in the progress of CHD since it is believed that oxidative injuries are involved in the etiology of CHD[16]. Variants of HSPA8 gene could affect HSPA8 levels and/or function. HSPA8 might take part in the development of CHD by two ways. First, as mentioned above it is believed that reactive oxygen species (ROS) are involved in the etiology of CHD[16]-[18]. This Hsp could protect against endogenous or exogenously generated ROS[5] and thus contribute to the progression of CHD. Second, this protein has also been reported to protect against hypoxia-induced apoptosis in hypoxia-induced apoptosis-resistant macrophages[19] and in the control of apoptosis during embryogenesis[20]. Other studies have found that HSPA8 protects cells against injuries by suppressing of apoptosis signaling and that its overexpression results in resistance against stress-induced caspase activation[4], [21]. Although to our knowledge no previous studies have investigated the role of HSPA8 in endothelium cells apoptosis, it might protect endothelium cells against apoptosis, which is believed to be the initiating event of atherogenesis and plays a crucial role in the transition from a stable endothelialized plaque to plaque erosion and thrombosis[22].
###end p 43
###begin p 44
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Dixon1">[23]</xref>
###xml 716 721 <span type="species:ncbi:9606">human</span>
SNPs in the promoter of the HSPA8 gene might affect its level of transcription and then lead to similar changes at the protein level. The SNP rs2236659 locates 357 bp upstream of transcriptional start code. In silico analysis using bioinformatics softwares of Alibaba2.0 (Niels Grabe, ) and TESS program (), predicts that the C allele has stronger binding capacity with transcriptional factor sp1 when compared with the T allele. Consistent with the computation, our study confirmed that C allele of SNP rs2236659 leads to an increase in promoter activity and probably heightens synthesis level of the corresponding HSPA8 protein which could decreases the risk of CHD. By using global expression data available from human lymphoblastoid cell lines[23], we did not find any evidence that rs2236659 directly influences HSPA8 expression. However, further studies conducted in cardiac tissues, vascular smooth muscle and/or endothelial cells would be necessary to draw conclusions about the possible effects of the rs2236659 SNP on HSPA8 expression.
###end p 44
###begin p 45
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 797 801 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Wu1">[24]</xref>
###xml 1397 1402 1393 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 539 547 <span type="species:ncbi:9606">patients</span>
Several strengths of this study should be acknowledged. First, our population is racially homogeneous (all Han Chinese), which weakens the possible biases from population stratification. In addition, the findings from case-control association study were confirmed by detailed functional assays in both endothelial and nonendothelial cell lines strengthened the association of the HSPA8 gene variations and CHD. However, three major limitations should also be mentioned. Firstly, like all case-control studies, selection bias (inclusion of patients surviving CHD) may exist and might influence interpretation of the results. Secondly, the controls selected without performing coronary angiography might include some false negative cases. However, because the prevalence of CHD in China is still low[24], and our controls all had normal ECG and no clinical symptoms before enrollment, the false negative cases in the controls are likely to be rare. Finally, replication is the best way to validate an association, however, the present matched case-control study is well designed and had enough power (>80%) to detect SNPs with risk ratios >1.35, 1.30, and 1.25, given an alpha of 0.05 and allele frequencies of 0.1, 0.3, and 0.5, respectively. In addition, our detailed functional assays conducted in both endothelial and nonendothelial cell lines confirmed and strengthened the associations of the HSPA8 gene variations and CHD. However, these associations still need to be validated in other ethnic groups.
###end p 45
###begin p 46
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
In summary, our case-control study and reporter assays results suggest that variants in HSPA8 gene contribute to CHD susceptibility. Future studies are needed to validate these findings and further investigate potential mechanisms underlying the links between variations of HSPA8 gene and CHD risk.
###end p 46
###begin title 47
Materials and Methods
###end title 47
###begin title 48
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
Screening for SNPs in HSPA8 Gene
###end title 48
###begin p 49
###xml 139 144 139 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 749 757 749 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009684.s001">Table S1</xref>
###xml 749 758 749 758 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0009684.s001">Table S1</xref>.</bold>
DNA samples extracted from whole blood of 60 randomly selected healthy Han Chinese (28 males and 32 females) were used to identify SNPs in HSPA8 gene (GenBank accession NM_006597.3). Resequencing region included all HSPA8 exons and introns and 1 Kb upstream of the transcript start site. Genomic DNA was amplified and then purified using the ethanol/NaAc method. The PCR products were used as templates for sequencing reactions with the BigDye Terminator kit v3.1 (Applied Biosystems, Foster City, CA, USA). Purified sequencing reactions were run on an ABI 3100 genetic analyzer. Sequence analysis, SNP detection, and genotype were performed using Sequencing Analysis 5.1.1 and DNAStar software. All primers and reaction conditions are displayed in Table S1.
###end p 49
###begin title 50
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Subjects
###end title 50
###begin p 51
###xml 67 71 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-He2">[12]</xref>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
###xml 848 856 <span type="species:ncbi:9606">patients</span>
The study design for this investigation has been described earlier [12]. Briefly, the study population was composed of 1,003 case patients and 1,003 age- (+/-5 years) and sex- frequency matched controls. All enrolled subjects were unrelated ethnic Han Chinese. CHD cases were enrolled from three hospitals (Tongji Hospital, Union Hospital, and Wugang Hospital) in Wuhan (Hubei, China) between May 2004 and October 2006. These cases were diagnosed according to WHO criteria or by coronary angiography (significant coronary artery stenoses >/=50% in at least one major coronary artery). Myocardial infarction was diagnosed by a representative set of ECG, cardiac enzyme values, and typical symptoms. Angina was defined as use of nitroglycerine, experience of typical chest pain, or ECG changes compatible with ischemic heart disease. In total, 1,078 patients diagnosed as having CHD were recruited; 1,003 of them (93.0%) consented to participate in the study and provided questionnaire information and blood samples. The control subjects resided in the same city as the cases and were judged to be free of CHD and peripheral atherosclerotic arterial disease by medical history, clinical examinations, and electrocardiography. The response rate for the controls was 92.4% (1,003 of 1,085). Sociodemographic information, past history, family history of cardiovascular disease, and lifestyle factors were obtained through questionnaire interview.
###end p 51
###begin p 52
Subjects were classified as nonsmokers, former, or current smokers. Habitual physical activity was classified into four groups: little, light, moderate and vigorous. Subjects were considered to be hypertensive if their systolic blood pressure was >/=140 mmHg and/or diastolic pressure >/=90 mmHg or if they were already being treated with antihypertensive drugs. All subjects gave written consent after receiving a full explanation of the study. The Ethics Committee of Tongji Medical College approved this study.
###end p 52
###begin title 53
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
Genotyping of HSPA8 Polymorphisms
###end title 53
###begin p 54
###xml 400 405 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#181;</italic>
###xml 432 437 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#181;</italic>
###xml 519 524 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#181;</italic>
###xml 1042 1050 1012 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009684.s002">Table S2</xref>
###xml 1042 1050 1012 1020 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0009684.s002">Table S2</xref></bold>
Fasting venous blood was collected in 5 ml heparin tubes, and genomic DNA was isolated with a Puregene kit (Gentra Systems, Inc., Minneapolis, MN, USA). Genotyping was performed with TaqMan SNP allelic discrimination method on an ABI 7900HT real-time quantitative polymerase chain reaction (PCR) system (Applied Biosystems), in 384-well format. PCR reactions were carried out in reaction volume of 5 microl containing 5 ng DNA, 2.5 microl 2x TaqMan universal PCR Master Mix, No AmpErase UNG (Applied Biosystems), 0.125 microl 40x Assay Mix (Applied Biosystems). PCR conditions included 95degreesC for 10 min followed by 40 cycles of 15 s at 92degreesC and 1 min at 60degreesC. Two blank controls (DNA hydration solution) and two replicate quality control samples were included in each 384-well format, and two replicate samples were genotyped with 100% concordance. The intensity of each SNP met the criteria of three clear clusters in two scales generated by SDS software (Applied Biosystems). The TaqMan primers and probes are displayed in Table S2. Finally, genotyping failed in 13 (1.30%), 9 (0.90%), 11 (1.10%) and 24 (2.40%) controls and 38 (3.80%), 33 (3.3 0%), 36(3.60%) and 44 (4.40%) cases in rs1461496, rs10892958, rs2276077 and rs2236659 locus respectively owing to DNA quantity or quality.
###end p 54
###begin title 55
Reporter Plasmids Construction
###end title 55
###begin p 56
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 376 385 376 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">the HSPA8</italic>
###xml 610 615 610 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 617 625 617 625 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3</bold>
###xml 617 625 617 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009684-g003"><bold>Figure 3</bold></xref>
###xml 702 710 702 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009684.s003">Table S3</xref>
###xml 702 710 702 710 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0009684.s003">Table S3</xref></bold>
Because rs2236659 (-357T/C) was associated with CHD risk and located in the core promoter region of HSPA8, we evaluated whether this variant had allele-specific effect on its transcriptional activity. We constructed plasmid containing 3 promoter SNPs (rs2236660 [-703T/C], rs2236659 [-357T/C], and rs2236658 [-308A/G]). Firstly, we amplified the -1 to -780 promoter region of the HSPA8 gene, and then inserted it into Kpn I/Hind III enzyme sites of pGL3-Basic (Promega, Madison, Wisconsin, USA). The first constructed plasmid contained the T-T-A haplotype (from left to right: -703T/C, 357T/C, and -308A/G) of HSPA8 (Figure 3). Primer pairs of amplification and site-specific mutagenesis are listed in Table S3. The direction and sequence authenticity of the above constructs were validated by restriction analysis and direct sequencing.
###end p 56
###begin title 57
Transient Transfection and Luciferase Reporter Assays
###end title 57
###begin p 58
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 315 319 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Human umbilical vein endothelial cells (HUVEC) and human bronchial epithelial cells (HBE) with density of 6x104 were seeded into 48-well plates and transfected with 100 ng pGL3-Basic plasmids or its constructs (defined as -703T/-357T/-308A, -703T/-357T/-308G, -703T/-357C/-308G, and -703C/-357C/-308G) and 1 ng pRL-SV40 (Promega) using Lipofectamine 2000 (Invitrogen, Carlsbad, California, USA) when grown to 70% confluence. Luciferase activity was measured at 24-hr using Dual-Luciferase Reporter Assay System (Promega) on a TD-20/20n luminometer (Turner Design, Promega). Each construct was tested in triplicates and the transfection experiments were performed three times independently. The results are denoted as relative luciferase activity (RLA) since the luciferase activity was normalized by Renilla luciferase activity and the empty pGL3-Basic vector.
###end p 58
###begin title 59
Biological Variables Determination
###end title 59
###begin p 60
Fasting blood glucose (FBG), total cholesterol (TC), and triglyceride (TG) were assayed using standard laboratory procedures at the Department of Clinical Laboratory at the Wuhan Union Hospital.
###end p 60
###begin title 61
Statistical Analysis
###end title 61
###begin p 62
###xml 419 424 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA8</italic>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Carter1">[25]</xref>
###xml 534 538 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Ding2">[26]</xref>
###xml 594 598 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HSPA</italic>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Ding1">[11]</xref>
###xml 712 716 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009684-Stephens1">[13]</xref>
###xml 718 719 718 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
A chi-square test was applied to compare categorical variables and the Hardy-Weinberg equilibrium of the polymorphisms. A multiple logistic regression analysis was used to evaluate the association between SNPs and CHD with appropriate adjustment of cardiovascular risk factors. The ANOVA test was used to examine the differences in luciferase reporter gene expression. The linkage relationship between the four SNPs in HSPA8 gene was measured by the linkage disequilibrium (LD) coefficient (D') calculating by JLIN[25] and LDA program[26]. The htSNPer1.0 software was used to select tagSNPs in HSPA8gene[11]. All genotype data for each sample were taken to construct the haplotypes by using the PHASE 2.0 program[13]. P<0.05 was considered statistically significant. All data analyses were carried out using SPSS 12.0 software (SPSS Inc., Chicago, Illinois, USA). Power calculations were performed using Quanto 1.2.3 (available from ).
###end p 62
###begin title 63
Supporting Information
###end title 63
###begin p 64
Primers and PCR conditions for sequencing HSPA8 gene.
###end p 64
###begin p 65
(0.06 MB DOC)
###end p 65
###begin p 66
Click here for additional data file.
###end p 66
###begin p 67
Primers and probes for genotyping 4 TagSNPs in HSPA8 gene.
###end p 67
###begin p 68
(0.03 MB DOC)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin p 70
Primer sequences used in amplification and reporter plasmids construction.
###end p 70
###begin p 71
(0.03 MB DOC)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
We would like to thank all individuals who voluntarily participated in the present study and the medical assistants of Tongji Hospital, Union Hospital and Wugang Hospital in Wuhan city, Hubei Province, China.
###end p 73
###begin title 74
References
###end title 74
###begin article-title 75
Molecular chaperones in cellular protein folding.
###end article-title 75
###begin article-title 76
###xml 39 44 <span type="species:ncbi:9606">human</span>
Guidelines for the nomenclature of the human heat shock proteins.
###end article-title 76
###begin article-title 77
The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions.
###end article-title 77
###begin article-title 78
Many mechanisms for hsp70 protection from cerebral ischemia.
###end article-title 78
###begin article-title 79
Stable overexpression of the constitutive form of heat shock protein 70 confers oxidative protection.
###end article-title 79
###begin article-title 80
Constitutive and inducible hsp70s are involved in oxidative resistance evoked by heat shock or ethanol.
###end article-title 80
###begin article-title 81
Differential distribution of 70-kD heat shock protein in atherosclerosis. Its potential role in arterial SMC survival.
###end article-title 81
###begin article-title 82
Reduction in myocardial apoptosis associated with overexpression of heat shock protein 70.
###end article-title 82
###begin article-title 83
Analysis of the association of a heat shock protein70-1 gene promoter polymorphism with myocardial infarction and coronary risk traits.
###end article-title 83
###begin article-title 84
Functional SNPs in HSPA1A gene predict risk of coronary heart disease.
###end article-title 84
###begin article-title 85
htSNPer1.0: software for haplotype block partition and htSNPs selection.
###end article-title 85
###begin article-title 86
Genetic variation in heat shock protein 60 gene and coronary heart disease in China: tagging-SNP haplotype analysis in a case-control study.
###end article-title 86
###begin article-title 87
A comparison of bayesian methods for haplotype reconstruction from population genotype data.
###end article-title 87
###begin article-title 88
Mechanism of substrate recognition by Hsp70 chaperones.
###end article-title 88
###begin article-title 89
HSP27 and HSP70: potentially oncogenic apoptosis inhibitors.
###end article-title 89
###begin article-title 90
The role of reactive oxygen species in atherosclerosis.
###end article-title 90
###begin article-title 91
Antioxidants and atherosclerotic heart disease.
###end article-title 91
###begin article-title 92
At last, direct evidence that lipoxygenases play a role in atherogenesis.
###end article-title 92
###begin article-title 93
Inflammatory mediators are perpetuated in macrophages resistant to apoptosis induced by hypoxia.
###end article-title 93
###begin article-title 94
Modulation of the chaperone heat shock cognate 70 by embryonic (pro)insulin correlates with prevention of apoptosis.
###end article-title 94
###begin article-title 95
The chaperone function of hsp70 is required for protection against stress-induced apoptosis.
###end article-title 95
###begin article-title 96
In vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion.
###end article-title 96
###begin article-title 97
A genome-wide association study of global gene expression.
###end article-title 97
###begin article-title 98
Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults.
###end article-title 98
###begin article-title 99
JLIN: a java based linkage disequilibrium plotter.
###end article-title 99
###begin article-title 100
LDA-a java-based linkage disequilibrium analyzer.
###end article-title 100
###begin p 101
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 101
###begin p 102
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the National Natural Science Foundation (grant NSFC-30525031 and NSFC-30430590) and a China-Canada Joint Health Research Grant of the Canadian Institutes of Health Research (CIHR) and the National Natural Science Foundation (grant NSFC- 30711120579) to RMT and TW. FBH's work was supported in part by the American Heart Association Established Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 102

